A new trial finds that intravenous immunoglobulin stabilises kidney function and slows damage in patients with chronic ...

This article discusses the differences and similarities between nivolumab subcutaneous injections and IV infusions for RCC to help people make the most suitable decisions for their treatment.

“Subcutaneous immunoglobulin is particularly interesting,” said Akiko Iwasaki, director of Yale’s Center for Infection & Immunity. Previous studies with intravenous immunoglobulin, or ...

“Hospitals use Intravenous Immunoglobulin (IVIG ... related disorders,” the report said. Furthermore, Subcutaneous Immunoglobulin (SCIg) is gaining traction in homecare settings, particularly ...

HyQvia is the only up to once monthly (every 2, 3 or 4 weeks) immunoglobulin subcutaneous infusion ... therapy after stabilization with intravenous immunoglobulin (IVIG) to prevent relapse of ...

A first-of-its-kind clinical trial clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous ...

Intravenous immunoglobulin (IVIg) treatment can help you fight off infections if you have a weakened immune system or other diseases. Some people may have IVIg instead of other medications (such ...

has approved an expanded label for XEMBIFY ®, the company’s 20% subcutaneous immunoglobulin (SCIg), to include treatment-naïve patients with primary humoral immunodeficiencies (PI).

These studies showed that HYQVIA maintained stable IgG levels comparable to intravenous or other subcutaneous immunoglobulin treatments, with manageable side effects such as mild fever and ...